Shiv Hari Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 09-12-2024
- Paid Up Capital ₹ 2.50 M
as on 09-12-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.10 Cr
as on 09-12-2024
- Revenue 10.18%
(FY 2023)
- Profit 170.36%
(FY 2023)
- Ebitda -268.11%
(FY 2023)
- Net Worth -11.54%
(FY 2023)
- Total Assets -15.78%
(FY 2023)
About Shiv Hari Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹6.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Latha Jain, Chandragupta Jain, Kishindas Shivaprasad, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232KA2000PTC027835
- Company No.
027835
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shiv Hari Pharmaceuticals Private Limited offer?
Shiv Hari Pharmaceuticals Private Limited offers a wide range of products and services, including Favipiravir Tablet, FabiFlu Tablet, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Shiv Hari Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandragupta Jain  | Director | 21-Sep-2000 | Current |
| Latha Jain | Director | 21-Sep-2000 | Current |
| Kishindas Shivaprasad | Director | 21-Sep-2000 | Current |
| Uma Shivaprasad | Director | 21-Sep-2000 | Current |
| Harish Darera | Director | 21-Sep-2000 | Current |
Financial Performance and Corporate Structure Insights of Shiv Hari Pharmaceuticals.
Shiv Hari Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.18% increase. The company also saw a substantial improvement in profitability, with a 170.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiv Hari Pharmaceuticals?
Unlock access to Shiv Hari Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aushad Distributors Private LimitedActive 17 years 8 monthsChandragupta Jain and Harish Darera are mutual person
- Aushad Pharmacies Private LimitedActive 3 years 8 months
Chandragupta Jain and Harish Darera are mutual person
- Aushad Pharma Distributors Private LimitedActive 6 years 7 days
Chandragupta Jain and Harish Darera are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 24 Apr 2017 | ₹3.50 Cr | Satisfied |
State Bank Of India Creation Date: 28 May 2011 | ₹2.00 Cr | Satisfied |
Federal Bank Ltd Creation Date: 08 Aug 2008 | ₹6.00 M | Satisfied |
How Many Employees Work at Shiv Hari Pharmaceuticals?
Shiv Hari Pharmaceuticals has a workforce of 12 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiv Hari Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiv Hari Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
